Q-omics provides the consensus-scored RPLP1P10 profile across patient tissues and cancer cell-line models. RPLP1P10 expression is associated with patient survival in 6 of 34 cancer types, with the highest sampling consensus in COAD. Additionally, RPLP1P10 RNA expression shows 3,380 significant pathway-activity associations, with the highest sampling consensus in OV. Together, these results highlight COAD, and OV as cancer lineages where RPLP1P10 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.